Anbio Biotechnology

NNNN - Company ID 0001982708

Market cap$1.50 B

Rank#2355

Filings40

Anbio Biotechnology has filed 40 public company documents between 2023 and 2026. The most frequent type is 6-k (7 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchNNNN overview$1.50 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #2355See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with IDXXPeer viewPut NNNN beside IDXX across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow NNNN via RSS

Similar companies to research next

IDXXIDEXX Laboratories, Inc.LLNTHLantheus Holdings, Inc.

CLDXCelldex Therapeutics, Inc.

NTLAIntellia Therapeutics, Inc.

NEOGNeogen Corporation

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
6-K	6-K	1mo ago2026-05-19	2026-05-19	View filing
6-K	6-K	2mo ago2026-04-27	2026-04-27	View filing
20-F/A	20-F/A	3mo ago2026-04-09	2025-12-31	View filing
3	New insider ownership	3mo ago2026-04-08	2026-03-18	View filing
3	New insider ownership	3mo ago2026-04-08	2026-03-18	View filing
3	New insider ownership	3mo ago2026-04-08	2026-03-18	View filing
3	New insider ownership	3mo ago2026-04-08	2026-03-18	View filing
3	New insider ownership	3mo ago2026-04-08	2026-03-18	View filing
20-F	20-F	3mo ago2026-04-07	2025-12-31	View filing
6-K	6-K	4mo ago2026-02-17	2026-02-17	View filing
6-K	6-K	5mo ago2026-01-26	2026-01-26	View filing
6-K	6-K	6mo ago2025-12-30	2025-12-30	View filing
6-K	6-K	7mo ago2025-11-13	2025-11-12	View filing
20-F	20-F	1y ago2025-04-28	2024-12-31	View filing
6-K	6-K	1y ago2025-02-21	2025-02-21	View filing
424B4	424B4	1y ago2025-02-19	-	View filing
EFFECT	EFFECT	1y ago2025-02-18	-	View filing
CERT	Exchange certification	1y ago2025-02-18	-	View filing
CORRESP	Company correspondence	1y ago2025-02-14	-	View filing
CORRESP	Company correspondence	1y ago2025-02-14	-	View filing
8-A12B	8-A12B	1y ago2025-02-14	-	View filing
F-1/A	F-1/A	1y ago2025-02-10	-	View filing
F-1/A	F-1/A	1y ago2025-01-24	-	View filing
FWP	Free writing prospectus	1y ago2025-01-22	-	View filing
F-1/A	F-1/A	1y ago2025-01-10	-	View filing
F-1	F-1	1y ago2024-12-31	-	View filing
DRSLTR	DRSLTR	1y ago2024-12-11	-	View filing
DRS/A	DRS/A	1y ago2024-12-11	-	View filing
UPLOAD	SEC correspondence	1y ago2024-12-04	-	View filing
DRS/A	DRS/A	1y ago2024-11-18	-	View filing
DRSLTR	DRSLTR	2y ago2024-07-01	-	View filing
DRS/A	DRS/A	2y ago2024-07-01	-	View filing
UPLOAD	SEC correspondence	2y ago2024-06-21	-	View filing
DRS/A	DRS/A	2y ago2024-06-10	-	View filing
DRSLTR	DRSLTR	2y ago2024-06-07	-	View filing
UPLOAD	SEC correspondence	2y ago2024-03-22	-	View filing
DRS/A	DRS/A	2y ago2024-03-11	-	View filing
DRSLTR	DRSLTR	2y ago2024-03-08	-	View filing
UPLOAD	SEC correspondence	2y ago2024-01-23	-	View filing
DRS	DRS	2y ago2023-12-27	-	View filing

Anbio Biotechnology

Similar companies to research next

Year